Jasmine M. Whyte is a technology specialist and patent agent in the New York office of Fish & Richardson P.C. Prior to joining the firm, Dr. Whyte (née De Cock) earned her Ph.D. in biology from Dr. Robert Weinberg’s laboratory at the Whitehead Institute for Biomedical Research/Massachusetts Institute of Technology (MIT), where she investigated the role of inflammation in the awakening of dormant disseminated cancer cells. Dr. Whyte has experience working in both the pharmaceutical research industry as well as in academia. As part of her undergraduate degree at King’s College of London (U.K.), Dr. Whyte was an industrial placement student at Pfizer in Sandwich, U.K., where she worked in a multi-disciplinary group on high-throughput assay development.
Dr. Whyte’s practice focuses on patent prosecution and counseling in the life sciences (including cancer biology, cellular and molecular biology immunology, biochemistry, and molecular genetics). Dr. Whyte manages patent portfolios and assists with due diligence and freedom-to-operate studies. In 2015, Dr. Whyte was an intern in the Boston office of Fish & Richardson as part of the MIT Alumni Association Externship Program.
As 1L at Columbia Law School, Dr. Whyte participated in the 1L Leadership Council on Legal Diversity (LCLD) Scholars Program. Dr. Whyte was the recipient of the 2020 NY IP Law Education Foundation (NYIPLEF) Diversity Scholarship.
Publications and Speaking Engagements
*Last name was previously De Cock.
Keckesova, Z, Donaher, J.L., De Cock, J., Freinkman, E., Lingrell, S., Bachovchin, D.A., Bierie, B., Tischler, V., Noske, A., Okondo, M.C., Reinhardt, F., Thiru, P., Golub, T.R., Vance, J.E., Weinberg, R.A. LACTB is a tumour suppressor that modulates lipid metabolism and cell state. Nature March 2017: 543(7647): 681-686.
Dance Partners Janssen and Celltrion Face Off in Trial Scheduled for February 2017, co-written with Tasha Francis and Jenny Shmuel, Fish Litigation Blog, February 7, 2017.
De Cock JM, Shibue T, Dongre A, Keckesova Z, Reinhardt F, Weinberg RA. Inflammation triggers Zeb1-dependent escape from tumor latency. Cancer Research 2016 Dec 1;76(23):6778-6784.
Spiegel, A., Brooks, M., Houshyar, S., Reinhardt, F., Ardolino, M., Fessler, E., Chen, M.B., Krall, J.A., De Cock, J., Zervanktonakis, I.K., Iannello, A., Iwamoto, Y., Cortez-Retamozo, V., Kamm, R.D., Pittet, M.J., Raulet, D., Weinberg, R.A. Neutrophils suppress intraluminal NK-mediated tumor cell clearance and enhance extravasation of disseminated carcinoma cells Cancer Discov 2016 June; (6): 630-49.
MIT – Ludwig Graduate Student Fellowship
1L Leadership Council on Legal Diversity (LCLD) Scholars Program
2020 NY IP Law Education Foundation (NYIPLEF) Diversity Scholarship
- Opinions and Strategic Counseling
- Patent Portfolio Management
- Patent Prosecution
- Startup and Early-Stage Companies
J.D., Columbia Law School (2021)
Ph.D., Biology, Massachusetts Institute of Technology (2016)
B.S. summa cum laude, Biochemistry, King's College London (2010)
B.A.C. with high honors, Lycée Pierre de Fermat (2006)
- U.S. Patent and Trademark Office 2018
NYIPLA Young Lawyers Committee (Co-Chair Spring 2021-present)
Member, New York IP Law Association (NYIPLA)
Member, ChIPs New York Chapter & Munich Chapter